A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Care Dx, Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 8,405 shares of CDNA stock, worth $180,035. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,405
Holding current value
$180,035
% of portfolio
0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$14.41 - $33.99 $121,116 - $285,685
8,405 New
8,405 $262,000
Q2 2022

Aug 15, 2022

SELL
$20.49 - $39.72 $179,779 - $348,503
-8,774 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$28.19 - $46.6 $535 - $885
-19 Reduced 0.22%
8,774 $325,000
Q4 2021

Feb 14, 2022

SELL
$41.2 - $73.6 $7,580 - $13,542
-184 Reduced 2.05%
8,793 $400,000
Q3 2021

Nov 15, 2021

BUY
$59.15 - $91.99 $6,033 - $9,382
102 Added 1.15%
8,977 $569,000
Q2 2021

Aug 16, 2021

SELL
$63.02 - $95.11 $3,087 - $4,660
-49 Reduced 0.55%
8,875 $812,000
Q1 2021

May 17, 2021

SELL
$57.62 - $95.6 $592,045 - $982,289
-10,275 Reduced 53.52%
8,924 $608,000
Q4 2020

Feb 16, 2021

SELL
$41.43 - $77.09 $51,828 - $96,439
-1,251 Reduced 6.12%
19,199 $1.39 Million
Q3 2020

Nov 16, 2020

SELL
$30.88 - $37.94 $4,076 - $5,008
-132 Reduced 0.64%
20,450 $776,000
Q2 2020

Aug 13, 2020

BUY
$18.95 - $35.43 $21,621 - $40,425
1,141 Added 5.87%
20,582 $729,000
Q1 2020

May 15, 2020

BUY
$13.94 - $28.25 $271,007 - $549,208
19,441 New
19,441 $424,000
Q3 2019

Nov 14, 2019

SELL
$20.03 - $40.08 $457,785 - $916,028
-22,855 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$25.78 - $39.77 $260,300 - $401,557
10,097 Added 79.14%
22,855 $823,000
Q1 2019

May 15, 2019

SELL
$22.09 - $39.21 $123,969 - $220,046
-5,612 Reduced 30.55%
12,758 $402,000
Q4 2018

Feb 14, 2019

BUY
$19.89 - $30.02 $365,379 - $551,467
18,370 New
18,370 $462,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.15B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track Joel Greenblatt's Portfolio

Track Joel Greenblatt Portfolio

Follow Joel Greenblatt (Gotham Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.